Cited by 5,092Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Molecular characterization of a peripheral receptor for cannabinoids

Munro, Sean, Thomas, Kerrie L., Abu-Shaar, Muna·1993·Nature

Open this paper in CoChat — free account

Abstract

The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.

Integrity signals

Registry

Crossref · 10.1038/365061a0

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
Collins, S. (1987) · Blood · doi:10.1182/blood.v70.5.1233.1233 · Cited by 1,189
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698
An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
Seed, B. (1987) · Nature · doi:10.1038/329840a0 · Cited by 674
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.
Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., & Civelli, O. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7432 · Cited by 659
ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM
Simmons, D., Makgoba, M. W., & Seed, B. (1988) · Nature · doi:10.1038/331624a0 · Cited by 616

Flagged first, then by citations

Show all 30 references

Research works printed but not linked: 8

Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
Reichman, M., Nen, W. & Hokin, L. E. Molec. Pharmac. 40, 547–555 (1991).
Munson, A. E. & Fehr, K. O. in Adverse Health and Behavioral Consequences of Cannabis Use (eds Fehr, K. O. & Kalant H.) 257–353 (Addiction Research Foundation, Toronto, 1983).
Robinson, A. P., White, T. M. & Mason, D. W. Immunology 57, 239–247 (1986).

Sorted by citations

Items 501–600 of 1,038

Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids: Figure 1.Preprint
Sullivan, J. (2000) · Learning & Memory · doi:10.1101/lm.7.3.132 · Cited by 175
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & PETROCELLIS, L. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 173
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
Roche, R., Hoareau, L., Bès-Houtmann, S., Gonthier, M., Laborde, C., Baron, J.-F., Haffaf, Y., Césari, M., & Festy, F. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0127-4 · Cited by 174
CB2 cannabinoid receptor mediation of antinociception
Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 173
Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway
del Pulgar, T. G., CEBALLOS, M. L. D., Guzmán, M., & Velasco, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205797200 · Cited by 173
Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells
Klein, T. W., & Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9007-x · Cited by 172
Fatty acid amide signaling molecules
Ezzili, C., Otrubova, K., & Boger, D. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.048 · Cited by 172
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Marzo, V. D., & Fontana, A. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 172
Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction.
Schuel, H., Goldstein, E., Mechoulam, R., Zimmerman, A. M., & Zimmerman, S. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7678 · Cited by 173
Constituents of Cannabis Sativa
Rock, E. M., & Parker, L. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_1 · Cited by 171
Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D. J., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
Kinsey, S. G., O'Neal, S. T., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.002 · Cited by 170
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 171
Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility
du Plessis, S. S., Agarwal, A. K., & Syriac, A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0553-8 · Cited by 171
Cardiovascular Pharmacology of Cannabinoids
Pacher, P., Bátkai, S., & Kunos, G. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_20 · Cited by 169
The current state and future perspectives of cannabinoids in cancer biology
Śledziński, P., Zeyland, J., Słomski, R., & Nowak, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1312 · Cited by 169
Medicinal Cannabis—Potential Drug Interactions
Alsherbiny, M. A., & Li, C. G. (2018) · Medicines · doi:10.3390/medicines6010003 · Cited by 170
Molecular and Cellular Mechanisms of Action of Cannabidiol
Naya, N. M., Kelly, J., Corna, G., Golino, M., Abbate, A., & Toldo, S. A. (2023) · Molecules · doi:10.3390/molecules28165980 · Cited by 169
Synergistic interactions of endogenous opioids and cannabinoid systems
Welch, S. P., & Eads, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01908-3 · Cited by 169
Aversive effects of the synthetic cannabinoid CP 55,940 in rats
McGregor, I. S., Issakidis, C. N., & Prior, G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02066-7 · Cited by 169
Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706348 · Cited by 168
The use of cannabinoids as anticancer agents
Velasco, G., Hernández‐Tiedra, S., Dávila, D., & Lorente, M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.010 · Cited by 168
Cannabinoid receptors: nomenclature and pharmacological principles
Console‐Bram, L., Marcu, J. P., & Abood, M. E. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.009 · Cited by 169
n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice
Watanabe, S., Doshi, M., & Hamazaki, T. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00056-5 · Cited by 168
Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells
Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 168
Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
Santucci, V., Storme, J.-J., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02319-4 · Cited by 168
Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein
Ellert‐Miklaszewska, A., Kaminska, B., & Konarska, L. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.05.011 · Cited by 168
Cannabinoids enhance human B‐cell growth at low nanomolar concentrations
Derocq, J., Ségui, M., Marchand, J., Fur, G. L., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 168
Cannabinoids in the treatment of glaucoma
Järvinen, T., Pate, D. W., & Laine, K. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00259-0 · Cited by 167
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00170-4 · Cited by 167
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Anand, U., Otto, W. R., Sanchez-Herrera, D., Facer, P., Yiangou, Y., Korchev, Y., Birch, R., Benham, C., Bountra, C., Chessell, I. P., et al. (2008) · Pain · doi:10.1016/j.pain.2008.06.007 · Cited by 166
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S. W., Wilson, S. J., Barbier, A., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706773 · Cited by 166
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Hernández‐Tiedra, S., Fabriàs, G., Dávila, D., Salanueva, Í. J., Casas, J., Montes, L. R., Antón, Z., García-Taboada, E., Salazar‐Roa, M., Lorente, M., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1213927 · Cited by 168
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response
PETROCELLIS, L. D., Melck, D. J., Bisogno, T., Milone, A., & Marzo, V. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00749-0 · Cited by 168
Identification of a high-affinity binding site involved in the transport of endocannabinoids
Moore, S. A., Nomikos, G. G., Chesterfield, A. K., Schober, D. A., Schaus, J. M., Ying, B.-P., Xu, Y., Phebus, L. A., Simmons, R. M. A., Li, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507470102 · Cited by 166
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 166
Microglia activation states and cannabinoid system: Therapeutic implications
Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.011 · Cited by 165
Sugars, Sweet Taste Receptors, and Brain Responses
Lee, A. A., & Owyang, C. (2017) · Nutrients · doi:10.3390/nu9070653 · Cited by 166
Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
Fox, S. H., Henry, B., Hill, M. P., Crossman, A. R., & Brotchie, J. M. (2002) · Movement Disorders · doi:10.1002/mds.10289 · Cited by 165
Role of cyclic AMP in the actions of cannabinoid receptors
Childers, S. R., & Deadwyler, S. A. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00419-4 · Cited by 165
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
Öz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 164
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Mock, E. D., Gagestein, B., & van der Stelt, M. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101194 · Cited by 164
A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis
Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 164
Cannabinoids and cell fate
Guzmán, M., Sánchez, C., & Galve‐Roperh, I. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00256-5 · Cited by 164
The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin
Patwardhan, A. M., Jeske, N. A., Price, T. J., Gamper, N. L., Akopian, A. N., & Hargreaves, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603861103 · Cited by 164
Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation
Paria, B. C., & Dey, S. K. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00197-3 · Cited by 164
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
Matias, I., Petrosino, S., Racioppi, A., Capasso, R., Izzo, A. A., & Marzo, V. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.026 · Cited by 163
Involvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling
Tam, J., Ofek, O., Fride, E., Ledent, C. A., Gabet, Y., Müller, R., Zimmer, A. D., Mackie, K., Mechoulam, R., Shohami, E., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026435 · Cited by 163
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
Mazur, A., Lichti, C. F., Prather, P. L., Zielinska, A. K., Bratton, S. M., Gallus‐Zawada, A. E., Finel, M., Miller, G. P., Radominska-p, A., & Moran, J. H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026898 · Cited by 165
Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB 1 receptor‐dependent G‐protein activation in rat cerebellar membranes
Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 163
CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids
McAllister, S. D., & Glass, M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0344 · Cited by 163
Synergistic efects of opioid and cannabinoid antagonists on food intake
Kirkham, T. C., & Williams, C. M. (2001) · Psychopharmacology · doi:10.1007/s002130000596 · Cited by 162
N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) Interaction with LYS 3.28(192) Is Crucial for Its Inverse Agonism at the Cannabinoid CB1 Receptor
Hurst, D. P., Lynch, D. L., Barnett‐Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D. L., & Reggio, P. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1274 · Cited by 161
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
Alberich-Jordà, M., Verbakel, S. E., Valk, P. J. M., Vankan, Y., Maccarrone, M., Finazzi-Agrò, A., Löwenberg, B., & Delwel, R. (2002) · Blood · doi:10.1182/blood.v99.8.2786 · Cited by 161
Cardiovascular Effects of Anandamide in Anesthetized and Conscious Normotensive and Hypertensive Rats
Lake, K. D., Martin, B. R., Kunos, G., & Varga, K. (1997) · Hypertension · doi:10.1161/01.hyp.29.5.1204 · Cited by 161
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
Guindon, J., Lai, Y., Takacs, S. M., Bradshaw, H. B., & Hohmann, A. G. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.013 · Cited by 160
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain
Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160
Cannabinoids, endocannabinoids, and cancer
Hermanson, D. J., & Marnett, L. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9318-8 · Cited by 160
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives
Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 161
The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells
Greenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 161
Endogenous Cannabinoid Signaling
Piomelli, D., Beltramo, M., Giuffrida, A., & Stella, N. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0221 · Cited by 160
A role for cannabinoid CB1 receptors in mood and anxiety disorders
Witkin, J. M., Tzavara, E. T., & Nomikos, G. G. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00005 · Cited by 160
Fatty acid amide hydrolase deficiency limits early pregnancy events
Wang, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28621 · Cited by 160
Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use
Ashtari, M., Cervellione, K., Cottone, J., Ardekani, B. A., & Kumra, S. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.002 · Cited by 159
Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes
Rhee, M., Bayewitch, M., Avidor‐Reiss, T., Levy, R., & Vogel, Z. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041525.x · Cited by 159
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
Tolón, R. M., Núñez, E., Pazos, M. R., Benito, C., Castillo, A. I., Martínez-Orgado, J. A., & Romero, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.098 · Cited by 159
Trajectory of adolescent cannabis use on addiction vulnerability
Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras‐Aswad, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.028 · Cited by 160
Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
Toth, C. C., Jedrzejewski, N. M., Ellis, C. L., & Frey, W. H. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-16 · Cited by 159
Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists
Lange, J. H. M., & Kruse, C. G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03427-6 · Cited by 160
Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System
McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35147-x · Cited by 160
Novel endogenous peptide agonists of cannabinoid receptors
Gomes, I., Grushko, J. S., Golebiewska, U. P., Hoogendoorn, S., Gupta, A., Heimann, A. S., Ferro, E. S., Scarlata, S., Fricker, L. D., & Devi, L. A. (2009) · The FASEB Journal · doi:10.1096/fj.09-132142 · Cited by 158
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 159
Endocannabinoids as cardiovascular modulators
Kunos, G., Járai, Z., Bátkai, S., Goparaju, S. K., Ishac, E. J. N., Liu, J., Wang, L., & Wagner, J. A. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00194-8 · Cited by 158
Δ9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors
Hejazi, N. S., Zhou, C., Öz, M., Sun, H., Ye, J. H., & Zhang, L. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.019174 · Cited by 158
Head Group Analogs of Arachidonylethanolamide, the Endogenous Cannabinoid Ligand
Khanolkar, A. D., Abadji, V., Lin, S., Hill, W. A. G., Taha, G., Abouzid, K. A. M., Meng, Z., Fan, P., & Makriyannis, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960152y · Cited by 158
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 157
Cannabis and endogenous cannabinoid systems
Childers, S. R., & Breivogel, C. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00075-1 · Cited by 157
Endogenous cannabinoids and appetite
Kirkham, T. C., & Williams, C. M. (2001) · Nutrition Research Reviews · doi:10.1079/095442201108729141 · Cited by 157
Adolescent exposure to cannabis as a risk factor for psychiatric disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405362 · Cited by 156
Expression of functional cannabinoid CB 2 receptor in VTA dopamine neurons in rats
Zhang, H., Gao, M., Shen, H., Bi, G., Yang, H., Liu, Q., Wu, J., Gardner, E. L., Bonci, A., & Xi, Z. (2016) · Addiction Biology · doi:10.1111/adb.12367 · Cited by 156
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Cassano, T., Villani, R., Pace, L., Carbone, A., Bukke, V. N., Orkisz, S., Avolio, C., & Serviddio, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00124 · Cited by 156
Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin
Dvorak, M., Watkinson, A., McGlone, F. P., & Rukwied, R. (2003) · Inflammation Research · doi:10.1007/s00011-003-1162-z · Cited by 156
Review article: endocannabinoids and their receptors in the enteric nervous system
Duncan, M., Davison, J. S., & Sharkey, K. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02648.x · Cited by 156
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, L., Luo, L., Palmer, J. A., Sutton, S., Wilson, S. J., Barbier, A. J., Breitenbucher, J. G., Chaplan, S. R., & Webb, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706699 · Cited by 155
Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples
Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., & Auwärter, V. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1877 · Cited by 155
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 155
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis
Preet, A., Qamri, Z., Nasser, M. W., Prasad, A., Shilo, K., Zou, X., Groopman, J. E., & Ganju, R. K. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0181 · Cited by 156
The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
Takahashi, K. A., & Castillo, P. E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.024 · Cited by 155
Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats
Smith, F. L., Fujimori, K., Lowe, J., & Welch, S. P. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00583-2 · Cited by 154
Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system
Griffin, G., Wray, E. J., Tao, Q., McAllister, S. D., Rorrer, W. K., Aung, M. M., Martin, B. R., & Abood, M. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00402-1 · Cited by 154
Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake
Matias, I., Bisogno, T., & Marzo, V. D. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803271 · Cited by 154
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Rajesh, M., Pan, H., Mukhopadhyay, P., Bátkai, S., Osei‐Hyiaman, D., Haskó, G., Liaudet, L., Gao, B., & Pacher, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307180 · Cited by 154
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
García-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling
Reisenberg, M., Singh, P. K., Williams, G. H., & Doherty, P. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0387 · Cited by 154
Endogenous cannabinoids revisited: A biochemistry perspective
Fonseca, B. M., Costa, M. A., Almada, M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.02.002 · Cited by 153
The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Bow, E. W., & Rimoldi, J. M. (2016) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s32171 · Cited by 153
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
Grabner, G. F., Zimmermann, R., Schicho, R., & Taschler, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.033 · Cited by 153
Cannabinoids as anticancer drugs: current status of preclinical research
Hinz, B., & Ramer, R. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01727-4 · Cited by 153
Identification and characterisation of a novel splice variant of the human CB1 receptor
Ryberg, E., Vu, H. K., Larsson, N., Groblewski, T., Hjorth, S., Elebring, T., Sjögren, S., & Greasley, P. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.085 · Cited by 154
Cannabinoids and cancer: pros and cons of an antitumour strategy
Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706632 · Cited by 153

Authors: Munro, S., Thomas, K. L., & Abu-Shaar, M.
Affiliations: MRC Laboratory of Molecular Biology (GB)
ORCID: Munro, Sean
Thomas, Kerrie L.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1993-09
Volume: 365
Issue: 6441
Pages: 61-65
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/365061a0
OpenAlex: W2056188558
Cited by: 5,092
References: 30
Citations by year: 2026: 76 · 2025: 119 · 2024: 165 · 2023: 172 · 2022: 198 · 2021: 244 · 2020: 212 · 2019: 184 · 2018: 169 · 2017: 188 · 2016: 182 · 2015: 175 · 2014: 188 · 2013: 201 · 2012: 202
FWCI: 39.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: cannabinoid receptors, delta-9-tetrahydrocannabinol, peripheral cannabinoid receptors, macrophages, receptor cloning, G protein-coupled receptors, immunosuppression, anti-inflammatory activity
MeSH terms: Amides, Amino Acid Sequence, Animals, Arachidonic Acids, Base Sequence, Brain, Cannabinoids, Cloning, Molecular, DNA, Fatty Acids, Unsaturated, Humans, Macrophages, Molecular Sequence Data, Morpholines, Naphthalenes, Receptors, Drug, RNA, Spleen, Tumor Cells, Cultured, Receptors, Cannabinoid, Benzoxazines, Rats, Polyunsaturated Alkamides, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular characterization of a peripheral receptor for cannabinoids

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks